JP2019535838A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019535838A5 JP2019535838A5 JP2019548536A JP2019548536A JP2019535838A5 JP 2019535838 A5 JP2019535838 A5 JP 2019535838A5 JP 2019548536 A JP2019548536 A JP 2019548536A JP 2019548536 A JP2019548536 A JP 2019548536A JP 2019535838 A5 JP2019535838 A5 JP 2019535838A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- carbocyclyl
- optionally substituted
- compound
- independently
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- NCVCXMQJGHKCEJ-UHFFFAOYSA-N COc(nc(cc1)OCC(F)(F)F)c1-c(cc1)n[n]2c1nnc2C(F)(F)F Chemical compound COc(nc(cc1)OCC(F)(F)F)c1-c(cc1)n[n]2c1nnc2C(F)(F)F NCVCXMQJGHKCEJ-UHFFFAOYSA-N 0.000 description 1
- XZEKABCXMDYBRO-UHFFFAOYSA-N Cc(nc(cc1)OCC(F)(F)F)c1-c(cc1)n[n]2c1nnc2C(F)(F)F Chemical compound Cc(nc(cc1)OCC(F)(F)F)c1-c(cc1)n[n]2c1nnc2C(F)(F)F XZEKABCXMDYBRO-UHFFFAOYSA-N 0.000 description 1
- WWQMLGJRTVRYOP-UHFFFAOYSA-N Cc1cc(-c(cc2)n[n]3c2nnc3C(F)(F)F)cnc1OCC(F)(F)F Chemical compound Cc1cc(-c(cc2)n[n]3c2nnc3C(F)(F)F)cnc1OCC(F)(F)F WWQMLGJRTVRYOP-UHFFFAOYSA-N 0.000 description 1
- NKCLROWBUFLEJR-UHFFFAOYSA-N Cc1cc(OCC(F)(F)F)ncc1-c(cc1)n[n]2c1nnc2C(F)(F)F Chemical compound Cc1cc(OCC(F)(F)F)ncc1-c(cc1)n[n]2c1nnc2C(F)(F)F NKCLROWBUFLEJR-UHFFFAOYSA-N 0.000 description 1
- LWGCKTVPPAQDBK-UHFFFAOYSA-N FC(COc(cc1)cnc1-c(cc1)n[n]2c1nnc2C(F)(F)F)(F)F Chemical compound FC(COc(cc1)cnc1-c(cc1)n[n]2c1nnc2C(F)(F)F)(F)F LWGCKTVPPAQDBK-UHFFFAOYSA-N 0.000 description 1
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022111844A JP7495962B2 (ja) | 2016-11-28 | 2022-07-12 | 化合物及びその使用方法 |
| JP2024084718A JP7801794B2 (ja) | 2016-11-28 | 2024-05-24 | 化合物及びその使用方法 |
| JP2025279047A JP2026062794A (ja) | 2016-11-28 | 2025-12-23 | 化合物及びその使用方法 |
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662427044P | 2016-11-28 | 2016-11-28 | |
| US62/427,044 | 2016-11-28 | ||
| US201762458306P | 2017-02-13 | 2017-02-13 | |
| US62/458,306 | 2017-02-13 | ||
| US201762552073P | 2017-08-30 | 2017-08-30 | |
| US62/552,073 | 2017-08-30 | ||
| PCT/US2017/063533 WO2018098499A1 (en) | 2016-11-28 | 2017-11-28 | Compounds and their methods of use |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022111844A Division JP7495962B2 (ja) | 2016-11-28 | 2022-07-12 | 化合物及びその使用方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019535838A JP2019535838A (ja) | 2019-12-12 |
| JP2019535838A5 true JP2019535838A5 (cg-RX-API-DMAC7.html) | 2021-01-07 |
| JP7105797B2 JP7105797B2 (ja) | 2022-07-25 |
Family
ID=62195384
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019548536A Active JP7105797B2 (ja) | 2016-11-28 | 2017-11-28 | 化合物及びその使用方法 |
| JP2022111844A Active JP7495962B2 (ja) | 2016-11-28 | 2022-07-12 | 化合物及びその使用方法 |
| JP2024084718A Active JP7801794B2 (ja) | 2016-11-28 | 2024-05-24 | 化合物及びその使用方法 |
| JP2025279047A Pending JP2026062794A (ja) | 2016-11-28 | 2025-12-23 | 化合物及びその使用方法 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022111844A Active JP7495962B2 (ja) | 2016-11-28 | 2022-07-12 | 化合物及びその使用方法 |
| JP2024084718A Active JP7801794B2 (ja) | 2016-11-28 | 2024-05-24 | 化合物及びその使用方法 |
| JP2025279047A Pending JP2026062794A (ja) | 2016-11-28 | 2025-12-23 | 化合物及びその使用方法 |
Country Status (14)
| Country | Link |
|---|---|
| US (3) | US11629146B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP4397308A3 (cg-RX-API-DMAC7.html) |
| JP (4) | JP7105797B2 (cg-RX-API-DMAC7.html) |
| CN (2) | CN110337295B (cg-RX-API-DMAC7.html) |
| AU (3) | AU2017364901A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112019010880A2 (cg-RX-API-DMAC7.html) |
| CA (2) | CA3281817A1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK3548033T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2992063T3 (cg-RX-API-DMAC7.html) |
| FI (1) | FI3548033T3 (cg-RX-API-DMAC7.html) |
| HU (1) | HUE068842T2 (cg-RX-API-DMAC7.html) |
| PL (1) | PL3548033T3 (cg-RX-API-DMAC7.html) |
| PT (1) | PT3548033T (cg-RX-API-DMAC7.html) |
| WO (1) | WO2018098499A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3281817A1 (en) | 2016-11-28 | 2026-03-02 | Praxis Precision Medicines, Inc. | Compounds and their methods of use |
| WO2018098491A1 (en) | 2016-11-28 | 2018-05-31 | Praxis Precision Medicines, Inc. | Compounds and their methods of use |
| US11492345B2 (en) | 2017-02-13 | 2022-11-08 | Praxis Precision Medicines, Inc. | Compounds and their methods of use |
| WO2018187480A1 (en) | 2017-04-04 | 2018-10-11 | Praxis Precision Medicines, Inc. | Compounds and their methods of use |
| US11278535B2 (en) | 2017-08-15 | 2022-03-22 | Praxis Precision Medicines, Inc. | Compounds and their methods of use |
| IL309843B2 (en) * | 2018-05-30 | 2026-05-01 | Praxis Prec Medicines Inc | History of [4,2,1]triazolo[3,4-a]pyridines and their use as sodium ion channel modulators |
| CA3110211A1 (en) | 2018-08-20 | 2020-02-27 | Rogcon, Inc. | Antisense oligonucleotides targeting scn2a for the treatment of scn1a encephalopathies |
| EA202092908A1 (ru) | 2018-09-28 | 2021-05-14 | Праксис Пресижн Медсинз, Инк. | Модуляторы ионных каналов |
| US11773099B2 (en) | 2019-05-28 | 2023-10-03 | Praxis Precision Medicines, Inc. | Compounds and their methods of use |
| US11279700B2 (en) | 2019-05-31 | 2022-03-22 | Praxis Precision Medicines, Inc. | Ion channel modulators |
| US11505554B2 (en) | 2019-05-31 | 2022-11-22 | Praxis Precision Medicines, Inc. | Substituted pyridines as ion channel modulators |
| WO2021039961A1 (ja) * | 2019-08-30 | 2021-03-04 | 大日本住友製薬株式会社 | 縮環ピラゾール誘導体 |
| JP2023503343A (ja) | 2019-11-26 | 2023-01-27 | プラクシス プレシジョン メディシンズ, インコーポレイテッド | イオンチャネルモジュレーター |
| US11767325B2 (en) | 2019-11-26 | 2023-09-26 | Praxis Precision Medicines, Inc. | Substituted [1,2,4]triazolo[4,3-a]pyrazines as ion channel modulators |
| PE20221280A1 (es) * | 2019-11-27 | 2022-09-05 | Praxis Prec Medicines Inc | Formulaciones de moduladores de canales ionicos y metodos de preparacion y uso de moduladores de canales ionicos |
| JP7880201B2 (ja) * | 2020-06-10 | 2026-06-25 | アムジエン・インコーポレーテツド | シクロプロピルジヒドロキノリンスルホンアミド化合物 |
| WO2023036934A1 (en) * | 2021-09-13 | 2023-03-16 | Boehringer Ingelheim Vetmedica Gmbh | Cyclopropyl-(hetero)aryl-substituted ethylsulphonylpyridine derivatives |
| KR20250005348A (ko) | 2022-04-26 | 2025-01-09 | 프락시스 프리시젼 메디신즈, 인크. | 신경 장애의 치료 |
| WO2024077273A2 (en) * | 2022-10-07 | 2024-04-11 | Denali Therapeutics Inc. | Compounds, compositions, and methods |
| WO2026082004A1 (zh) * | 2024-10-14 | 2026-04-23 | 上海京新生物医药有限公司 | 稠合杂芳基衍生物及其制备方法与应用 |
| CN119613413B (zh) * | 2024-12-26 | 2026-02-06 | 上海皓元医药股份有限公司 | 一种非唑奈坦的制备方法 |
Family Cites Families (70)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3845770A (en) | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
| CA1080712A (en) * | 1976-09-22 | 1980-07-01 | Jay D. Albright | Hypotensive agents |
| US4230705A (en) * | 1976-09-22 | 1980-10-28 | American Cyanamid Company | 6-Phenyl-1,2,4-triazolo[4,3-b]pyridazines and their uses in treating anxiety |
| US4112095A (en) * | 1976-10-07 | 1978-09-05 | American Cyanamid Company | 6-Phenyl-1,2,4-triazolo[4,3-b]pyridazine hypotensive agents |
| US4242515A (en) | 1979-03-28 | 1980-12-30 | American Cyanamid Company | Substituted 3-alkyl-6-phenyl-1,2,4-triazolo-[4,3-a]pyridines |
| US4326525A (en) | 1980-10-14 | 1982-04-27 | Alza Corporation | Osmotic device that improves delivery properties of agent in situ |
| US5364620A (en) | 1983-12-22 | 1994-11-15 | Elan Corporation, Plc | Controlled absorption diltiazem formulation for once daily administration |
| US5023252A (en) | 1985-12-04 | 1991-06-11 | Conrex Pharmaceutical Corporation | Transdermal and trans-membrane delivery of drugs |
| US4992445A (en) | 1987-06-12 | 1991-02-12 | American Cyanamid Co. | Transdermal delivery of pharmaceuticals |
| US5001139A (en) | 1987-06-12 | 1991-03-19 | American Cyanamid Company | Enchancers for the transdermal flux of nivadipine |
| US4902514A (en) | 1988-07-21 | 1990-02-20 | Alza Corporation | Dosage form for administering nilvadipine for treating cardiovascular symptoms |
| GB9507348D0 (en) * | 1995-04-08 | 1995-05-31 | Knoll Ag | Therapeutic agents |
| EP1301511A2 (en) | 2000-07-14 | 2003-04-16 | Bristol-Myers Squibb Pharma Company | IMIDAZO 1,2-a]PYRAZINES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS |
| JP4898445B2 (ja) * | 2003-05-29 | 2012-03-14 | シャイア エルエルシー | 乱用抵抗性アンフェタミン化合物類 |
| WO2005077953A1 (ja) * | 2004-02-18 | 2005-08-25 | Banyu Pharmaceutical Co., Ltd. | 含窒素縮合へテロ芳香環誘導体 |
| WO2006061428A2 (en) * | 2004-12-10 | 2006-06-15 | Universität Zürich | Gaba-a alpha 2 and alpha 3 receptor agonists for treating neuropathic, inflammatory and migraine associated pain |
| US20100088778A1 (en) | 2005-06-16 | 2010-04-08 | John Charles Mulley | Methods of Treatment, and Diagnosis of Epilepsy by Detecting Mutations in the SCN1A Gene |
| RS55630B1 (sr) | 2005-12-21 | 2017-06-30 | Janssen Pharmaceutica Nv | Triazolopiridazini kao modulatori tirozin kinaze |
| US8217177B2 (en) | 2006-07-14 | 2012-07-10 | Amgen Inc. | Fused heterocyclic derivatives and methods of use |
| US8198448B2 (en) | 2006-07-14 | 2012-06-12 | Amgen Inc. | Fused heterocyclic derivatives and methods of use |
| PE20121506A1 (es) | 2006-07-14 | 2012-11-26 | Amgen Inc | Compuestos triazolopiridinas como inhibidores de c-met |
| FR2915198B1 (fr) | 2007-04-18 | 2009-12-18 | Sanofi Aventis | Derives de triazolopyridine-carboxamides et triazolopyridine -carboxamides, leur preparation et leur application en therapeutique. |
| BRPI0908428A2 (pt) | 2008-02-06 | 2015-12-08 | Gilead Sciences Inc | uso de ranozalina para tratar a dor. |
| WO2010053757A1 (en) | 2008-10-29 | 2010-05-14 | Gilead Palo Alto, Inc. | 2 -oxoquinoxalin blockers of the late sodium channel |
| WO2010074807A1 (en) | 2008-10-30 | 2010-07-01 | Gilead Palo Alto, Inc. | 3, 4-dihydroquinolin-2 ( 1h ) -one derivatives as sodium channel modulators |
| US20100125091A1 (en) | 2008-11-14 | 2010-05-20 | Gilead Palo Alto, Inc. | Substituted heterocyclic compounds as ion channel modulators |
| AU2009330821B2 (en) | 2008-12-24 | 2015-06-11 | Bial - Portela & Ca, S.A. | Pharmaceutical compounds |
| JP5340798B2 (ja) | 2009-05-07 | 2013-11-13 | タイガースポリマー株式会社 | 地中埋設管の製造方法 |
| HRP20131122T1 (hr) | 2009-05-12 | 2013-12-20 | Janssen Pharmaceuticals, Inc. | Derivati 1,2,4-triazolo[4,3-a] piridina i njihova uporaba u lijeäśenju ili prevenciji neuroloških i psihijatrijskih poremeä†aja |
| HUE034911T2 (hu) * | 2009-07-27 | 2018-03-28 | Gilead Sciences Inc | Fúzionált heterociklusos vegyületek mint ioncsatorna modulátorok |
| WO2011056985A2 (en) | 2009-11-04 | 2011-05-12 | Gilead Sciences, Inc. | Substituted heterocyclic compounds |
| FR2953520B1 (fr) | 2009-12-04 | 2011-11-25 | Sanofi Aventis | Derives de diphenyl-pyrazolopyridines, leur preparation et leur application en therapeutique |
| EP2588107A1 (en) | 2010-07-01 | 2013-05-08 | Takeda Pharmaceutical Company Limited | COMBINATION OF A cMET INHIBITOR AND AN ANTIBODY TO HGF AND/OR cMET |
| EP2588197B1 (en) | 2010-07-02 | 2014-11-05 | Gilead Sciences, Inc. | Fused heterocyclic compounds as ion channel modulators |
| WO2012065297A1 (en) | 2010-11-16 | 2012-05-24 | Impact Therapeutics, Inc. | 3-ARYL-6-ARYL-[1,2,4]TRIAZOLO[4,3-a]PYRIDINES AS INHIBITORS OF CELL PROLIFERATION AND THE USE THEREOF |
| US9139576B2 (en) | 2011-05-03 | 2015-09-22 | Merck Sharp & Dohme Corp. | Aminomethyl biaryl benzotriazole derivatives |
| WO2012154760A1 (en) | 2011-05-10 | 2012-11-15 | Gilead Sciences, Inc. | Fused heterocyclic compounds as sodium channel modulators |
| NO3175985T3 (cg-RX-API-DMAC7.html) | 2011-07-01 | 2018-04-28 | ||
| WO2013043925A1 (en) | 2011-09-21 | 2013-03-28 | Gilead Sciences, Inc. | Sodium channel blockers reduce glucagon secretion |
| EP2760866B1 (en) | 2011-09-27 | 2017-12-13 | Genfit | Derivatives of 6-substituted triazolopyridazines as rev-erb agonists |
| CN103122000B (zh) * | 2012-09-03 | 2013-12-25 | 中美冠科生物技术(太仓)有限公司 | 用作抗肿瘤药物的高选择性的c-Met激酶抑制剂 |
| TWI574962B (zh) * | 2012-11-14 | 2017-03-21 | 加拓科學公司 | 作爲pi3激酶調節劑的芳雜環化合物及其使用方法和用途 |
| WO2014100764A2 (en) | 2012-12-21 | 2014-06-26 | Epizyme, Inc. | Methods of inhibiting prmt5 |
| US20140329755A1 (en) | 2013-05-01 | 2014-11-06 | Gilead Sciences, Inc. | Combination therapy for the treatment of arrhythmias or heart failure |
| KR102307566B1 (ko) | 2013-06-21 | 2021-10-05 | 제니쓰 에피제네틱스 리미티드 | 신규한 바이사이클릭 브로모도메인 억제제 |
| DK3035926T3 (da) | 2013-08-19 | 2020-08-31 | Univ California | Forbindelser og fremgangsmåder til behandling af en epilepsilidelse |
| GB201321740D0 (en) | 2013-12-09 | 2014-01-22 | Ucb Pharma Sa | Therapeutic agents |
| WO2015095370A1 (en) | 2013-12-19 | 2015-06-25 | Gilead Sciences, Inc. | Fused heterocyclic compounds as ion channel modulators |
| WO2015157955A1 (en) | 2014-04-17 | 2015-10-22 | Abbvie Inc. | Heterocyclic btk inhibit ors |
| US10030026B2 (en) * | 2014-06-04 | 2018-07-24 | Rugen Holdings (Cayman) Limited | Difluoroethylpyridine derivatives as NR2B NMDA receptor antagonists |
| EP3159366B1 (en) | 2014-06-20 | 2020-04-08 | Mitsubishi Chemical Corporation | Polycarbonatediol, method for producing same, and polyurethane produced using same |
| TWI713455B (zh) | 2014-06-25 | 2020-12-21 | 美商伊凡克特治療公司 | MnK抑制劑及其相關方法 |
| PE20161476A1 (es) | 2014-06-26 | 2017-01-07 | Hoffmann La Roche | Derivados de indolin-2-ona o pirrolo-piridin-2-ona |
| JP2017001991A (ja) | 2015-06-11 | 2017-01-05 | 大日本住友製薬株式会社 | 新規ベンズオキサゾロン化合物 |
| US11352328B2 (en) | 2016-07-12 | 2022-06-07 | Arisan Therapeutics Inc. | Heterocyclic compounds for the treatment of arenavirus |
| TW201819376A (zh) | 2016-10-06 | 2018-06-01 | 比利時商健生藥品公司 | 經取代之1H-咪唑並[4,5-b]吡啶-2(3H)-酮及其作為GLUN2B受體調節劑之用途 |
| CA3281817A1 (en) | 2016-11-28 | 2026-03-02 | Praxis Precision Medicines, Inc. | Compounds and their methods of use |
| WO2018098491A1 (en) | 2016-11-28 | 2018-05-31 | Praxis Precision Medicines, Inc. | Compounds and their methods of use |
| WO2018098500A1 (en) | 2016-11-28 | 2018-05-31 | Praxis Precision Medicines, Inc. | Compounds and their methods of use |
| US11492345B2 (en) | 2017-02-13 | 2022-11-08 | Praxis Precision Medicines, Inc. | Compounds and their methods of use |
| WO2018187480A1 (en) | 2017-04-04 | 2018-10-11 | Praxis Precision Medicines, Inc. | Compounds and their methods of use |
| US11278535B2 (en) | 2017-08-15 | 2022-03-22 | Praxis Precision Medicines, Inc. | Compounds and their methods of use |
| IL309843B2 (en) | 2018-05-30 | 2026-05-01 | Praxis Prec Medicines Inc | History of [4,2,1]triazolo[3,4-a]pyridines and their use as sodium ion channel modulators |
| EA202092908A1 (ru) | 2018-09-28 | 2021-05-14 | Праксис Пресижн Медсинз, Инк. | Модуляторы ионных каналов |
| US11773099B2 (en) | 2019-05-28 | 2023-10-03 | Praxis Precision Medicines, Inc. | Compounds and their methods of use |
| US11505554B2 (en) | 2019-05-31 | 2022-11-22 | Praxis Precision Medicines, Inc. | Substituted pyridines as ion channel modulators |
| US11279700B2 (en) | 2019-05-31 | 2022-03-22 | Praxis Precision Medicines, Inc. | Ion channel modulators |
| US11767325B2 (en) | 2019-11-26 | 2023-09-26 | Praxis Precision Medicines, Inc. | Substituted [1,2,4]triazolo[4,3-a]pyrazines as ion channel modulators |
| JP2023503343A (ja) | 2019-11-26 | 2023-01-27 | プラクシス プレシジョン メディシンズ, インコーポレイテッド | イオンチャネルモジュレーター |
| PE20221280A1 (es) | 2019-11-27 | 2022-09-05 | Praxis Prec Medicines Inc | Formulaciones de moduladores de canales ionicos y metodos de preparacion y uso de moduladores de canales ionicos |
-
2017
- 2017-11-28 CA CA3281817A patent/CA3281817A1/en active Pending
- 2017-11-28 CA CA3045121A patent/CA3045121C/en active Active
- 2017-11-28 US US16/464,468 patent/US11629146B2/en active Active
- 2017-11-28 EP EP24160394.3A patent/EP4397308A3/en active Pending
- 2017-11-28 DK DK17874657.4T patent/DK3548033T3/da active
- 2017-11-28 PL PL17874657.4T patent/PL3548033T3/pl unknown
- 2017-11-28 JP JP2019548536A patent/JP7105797B2/ja active Active
- 2017-11-28 CN CN201780084790.8A patent/CN110337295B/zh active Active
- 2017-11-28 PT PT178746574T patent/PT3548033T/pt unknown
- 2017-11-28 CN CN202310582446.9A patent/CN116763791A/zh active Pending
- 2017-11-28 WO PCT/US2017/063533 patent/WO2018098499A1/en not_active Ceased
- 2017-11-28 AU AU2017364901A patent/AU2017364901A1/en not_active Abandoned
- 2017-11-28 HU HUE17874657A patent/HUE068842T2/hu unknown
- 2017-11-28 BR BR112019010880-7A patent/BR112019010880A2/pt not_active Application Discontinuation
- 2017-11-28 EP EP17874657.4A patent/EP3548033B1/en active Active
- 2017-11-28 FI FIEP17874657.4T patent/FI3548033T3/fi active
- 2017-11-28 ES ES17874657T patent/ES2992063T3/es active Active
-
2022
- 2022-07-12 JP JP2022111844A patent/JP7495962B2/ja active Active
-
2023
- 2023-03-10 US US18/119,963 patent/US20230322790A1/en not_active Abandoned
- 2023-12-14 AU AU2023282271A patent/AU2023282271A1/en not_active Abandoned
-
2024
- 2024-05-24 JP JP2024084718A patent/JP7801794B2/ja active Active
- 2024-12-06 US US18/971,281 patent/US20250163068A1/en active Pending
-
2025
- 2025-09-23 AU AU2025237912A patent/AU2025237912A1/en active Pending
- 2025-12-23 JP JP2025279047A patent/JP2026062794A/ja active Pending